Pakistan regulators have approved final-phase testing of a Chinese-made vaccine against the coronavirus, officials said Tuesday, in the country's first ever clinical trial of its kind.

According to Pakistan's National Institute of Health (NIH), regulators have approved the testing of a vaccine under development by CanSinoBio and the Beijing Institute of Biotechnology China.

The medication is already undergoing Phase 3 trials -- or large-scale testing on humans -- in China, Russia, Chile and Argentina. Saudi Arabia will also take part, NIH said.

"This will be the first ever Phase 3 clinical trial for any vaccine in Pakistan," the NIH said in a statement.

Pakistan's inclusion in the trials would help it secure "preferential vaccine supply and pricing", it added.

The trials will be conducted at several medical facilities across Pakistan, including the large Indus Hospital in Karachi.

"Hopefully we will come out with the vaccine within three to four months," Abdul Bari, who heads the Indus Hospital, told AFP.

The coronavirus has claimed more than 6,000 lives in Pakistan but cases have been dropping for several weeks.

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

Global health emergencies: A rarely used call to action
Geneva (AFP) Jan 22, 2020
The World Health Organisation (WHO) is holding emergency talks Thursday in Geneva to decide whether a deadly virus outbreak in China constitutes a "public health emergency of international concern". The designation is rare and only used for the gravest outbreaks which are considered "serious, sudden, unusual or unexpected". The classification would imply that the disease, which has killed nine people so far, risks spreading further internationally and requires an international response. The ... read more